We are live on ! Find out more
MF

Magnetar Financial Portfolio holdings

AUM $9.84B
1-Year Est. Return 190.64%
This Fund
S&P 500
This Quarter Est. Return
-1.37%
1 Year Est. Return
+190.64%
3 Year Est. Return
+293.18%
5 Year Est. Return
+491.79%
10 Year Est. Return
+5,174.28%
AUM
$4.8B
AUM Growth
+$330M
Cap. Flow
+$1.96B
Cap. Flow %
40.8%
Top 10 Hldgs %
23.01%
Holding
660
New
296
Increased
60
Reduced
83
Closed
163

Top Buys

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$111M
2
SOLV icon
Solventum
SOLV
+$87.4M
3
JNJ icon
Johnson & Johnson
JNJ
+$82.2M
4
CHX
ChampionX
CHX
+$74.8M
5
SRCL
Stericycle Inc
SRCL
+$72.1M

Sector Composition

Rank Sector Weight
1 Healthcare 48.01%
2 Technology 8.53%
3 Financials 7.15%
4 Industrials 6.63%
5 Energy 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZBH icon
1
Zimmer Biomet
ZBH
$17.3B
$142M 2.96%
1,310,265
+484,816
+59% +$57.2M
NVS icon
2
Novartis
NVS
$297B
$139M 2.9%
1,305,446
-600,600
-32% -$60.3M
BDX icon
3
Becton Dickinson
BDX
$42.1B
$124M 2.57%
528,442
+223,358
+73% +$52.6M
SNY icon
4
Sanofi
SNY
$104B
$122M 2.54%
2,506,286
+2,306,286
+1,153% +$111M
ELAN icon
5
Elanco Animal Health
ELAN
$12.4B
$120M 2.51%
8,336,657
+3,164,350
+61% +$50.6M
GMED icon
6
Globus Medical
GMED
$10.2B
$118M 2.45%
1,718,487
+29,200
+2% +$1.74M
CVII
7
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
$89.5M 1.87%
8,306,005
JNPR
8
DELISTED
Juniper Networks
JNPR
$84.7M 1.77%
2,324,339
-9,545
-0.4% -$339K
WRK
9
DELISTED
WestRock Company
WRK
$83.4M 1.74%
1,658,921
-158,107
-9% -$7.98M
SRCL
10
DELISTED
Stericycle Inc
SRCL
$81.6M 1.7%
+1,403,679
New +$72.1M
ABT icon
11
Abbott
ABT
$175B
$81.3M 1.7%
782,794
+294,939
+60% +$31.3M
UNH icon
12
UnitedHealth
UNH
$385B
$81.1M 1.69%
159,239
+79,898
+101% +$39.2M
JNJ icon
13
Johnson & Johnson
JNJ
$624B
$80.8M 1.68%
+552,484
New +$82.2M
SWN
14
DELISTED
Southwestern Energy Company
SWN
$79.9M 1.67%
11,879,117
-481,169
-4% -$3.51M
SOLV icon
15
Solventum
SOLV
$13.4B
$78.8M 1.64%
1,490,410
+1,440,410
+2,881% +$87.4M
ACI icon
16
Albertsons Companies
ACI
$5.6B
$77.4M 1.61%
3,919,381
-15,375
-0.4% -$314K
AXNX
17
DELISTED
Axonics, Inc. Common Stock
AXNX
$76.7M 1.6%
1,141,334
-4,685
-0.4% -$316K
CHX
18
DELISTED
ChampionX
CHX
$72.9M 1.52%
+2,193,929
New +$74.8M
MGRC icon
19
McGrath RentCorp
MGRC
$2.92B
$72.3M 1.51%
678,429
-2,787
-0.4% -$307K
DFS
20
DELISTED
Discover Financial Services
DFS
$71.5M 1.49%
546,896
HCP
21
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
$71.5M 1.49%
+2,121,984
New +$66M
OPCH icon
22
Option Care Health
OPCH
$3.31B
$68.7M 1.43%
2,481,935
+1,377,929
+125% +$41.1M
ANSS
23
DELISTED
Ansys
ANSS
$67.1M 1.4%
208,837
-857
-0.4% -$281K
EHC icon
24
Encompass Health
EHC
$11B
$63.9M 1.33%
744,836
+371,818
+100% +$31.2M
COO icon
25
Cooper Companies
COO
$13.7B
$63.8M 1.33%
+731,060
New +$68.2M

Similar funds

Magnetar Financial's Q2 2024 Portfolio in Review

As of Q2 2024, Magnetar Financial held 660 positions worth $4.8B, up 7.4% from $4.47B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Magnetar Financial deployed $1.96B of net new capital in Q2 2024, opening 296 new positions and adding to 60 existing holdings. Its largest new stake was Johnson & Johnson: 552,484 shares worth $80.8M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 44% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Medtronic, an estimated $98.6M trimmed.

  • Magnetar Financial's largest Q2 2024 buy was Johnson & Johnson: 552,484 shares worth $80.8M.
  • Magnetar Financial added most to Sanofi in Q2 2024, an estimated $111M increase.
  • Magnetar Financial's biggest Q2 2024 reduction was Medtronic, cutting an estimated $98.6M.
  • Magnetar Financial fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $92.6M.
  • Magnetar Financial's ten largest holdings make up 23% of its $4.8B portfolio in Q2 2024.
  • Magnetar Financial opened 296 new positions and closed 163 in Q2 2024.
  • Magnetar Financial's portfolio value rose 7.4% quarter-over-quarter to $4.8B.

Based on Magnetar Financial's 13F filing for Q2 2024, filed 14 Aug 2024.